CAS 115279-73-7
:1-(4-Aminophényl)cyclopentanecarbonitrile
- Cyclopentanecarbonitrile, 1-(4-aminophenyl)-
- 1-(4-aminophenyl)-Cyclopentanecarbonitrile
- 1-(4-aminophenyl)cyclopentane-1-carbonitrile
Cyclopentanecarbonitrile, 1-(4-aminophenyl)-
CAS :Formule :C12H14N2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :186.25301-(4-Aminophenyl)cyclopentanecarbonitrile
CAS :1-(4-Aminophenyl)cyclopentanecarbonitrileDegré de pureté :98%Masse moléculaire :186.25g/mol1-(4-Aminophenyl)cyclopentanecarbonitrile
CAS :Formule :C12H14N2Degré de pureté :98%Couleur et forme :Liquid, No data available.Masse moléculaire :186.2581-(4-Aminophenyl)cyclopentanecarbonitrile
CAS :Produit contrôléFormule :C12H14N2Couleur et forme :NeatMasse moléculaire :186.2531-(4-Aminophenyl)cyclopentanecarbonitrile-d8
CAS :Produit contrôléApplications 1-(4-Aminophenyl)cyclopentanecarbonitrile-d8 is an intermediate used in the synthesis of Apatinib-d8 Hydrochloride (A726152), which is a labelled Apatinib (A726150). Apatinib is an orally available, small molecule multitargeted tyrosine kinase inhibitor. Apatinib selectively inhibits the vascular endothelial growth factor receptor-2 (VEGFR2). Apatinib functions by inhibiting VEGF-mediated endothelial cell migration and proliferation thus blocking new blood vessel formation in tumor tissue. Recent studies have shown that Apatinib enhances the efficacy of conventional chemotherapeutical drugs in side population (SP) cells and ABCB1-overexpressing leukemia cells.
References Mi, Y. et al.: Cancer Res., 70, 7981 (2010); Tong, X.Z. et al.: Biochem. Pharmacol., 83, 586 (2012); Ding, J, et al.: J. Chrom B Anal. Technol. Biomed. Life Sci., 895, 108 (2012);Formule :C12D8H6N2Couleur et forme :NeatMasse moléculaire :194.302



